HDAC3-mediated deacetylation of p21 stabilizes protein levels and promotes 5-FU resistance in colorectal cancer cells
Authors:
- Wei JinWJWei Jin
- Jue-Jue WangJWJue-Jue Wang
- Yan-Fei FengYFYan-Fei Feng
- Bing ChenBCBing Chen
- Zhao-Hua HuZHZhao-Hua Hu
Open Access
- 12 February 2025
- journal article
- Published by Elsevier in Advances in Cancer Biology - Metastasis
- Vol. 14
Abstract
No abstract availableFunding Information
- Zhejiang Province Natural Science Foundation (Q22H1610005)
- National Natural Science Foundation of China (82103500)
This publication has 30 references indexed in Scilit:
- Epigenetic modifications: Key players in cancer heterogeneity and drug resistanceTranslational Oncology, 2023
- Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseasesJournal of Molecular Medicine, 2021
- Global colorectal cancer burden in 2020 and projections to 2040Translational Oncology, 2021
- 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibitionBiomedicine & Pharmacotherapy, 2021
- Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A reviewEuropean Journal of Medicinal Chemistry, 2020
- 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and futurePharmacology & Therapeutics, 2020
- Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damageDNA Repair, 2016
- Base excision repair AP endonucleases and mismatch repair act together to induce checkpoint-mediated autophagyNature Communications, 2013
- p21 and p27: roles in carcinogenesis and drug resistanceExpert Reviews in Molecular Medicine, 2008
- HDAC3 overexpression and colon cancer cell proliferation and differentiationMolecular Carcinogenesis, 2007